1、公司名称：XINOVA ENVIRONMENT PTE.LTD. 注册国家（地区）：新加坡 证券代码：001358 证券简称：兴欣新材 公告编号：2024-029 绍兴兴欣新材料股份有限公司 关于对外投资设立合资公司并完成工商登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、对外投资概述 绍兴兴欣新材料股份有限公司（以下简称"公司"）为优化产业布局，延 伸产业链，全面提升公司可持续发展能力，以自有资金与外资 XINOVA ENVIRONMENT PTE. LTD.（以下简称"XINOVA"）、杭州诺信洁源环境科技合伙 企业(有限合伙)（以下简称"诺信洁源"），本着平等合作、互利共赢的原 则，共同出资设立"欣诺环境（浙江）有限公司（以下简称"合资公司"）。 其中：公司出资 615 万元，持有合资公司 51.25%的股权；股东 XINOVA 以货币 方式出资 435 万人民币元，持有合资公司 36.25%的股权、股东诺信洁源以货币 方式投入 150 万人民币元，持有合资公司 12.50%的股权。近日，公司完成了上 述事项的工商注册登记手续，并领取 ...

绍兴兴欣新材料股份有限公司（以下简称"公司"）近日收到国盛证券有限 责任公司（以下简称"国盛证券"）出具的《关于更换绍兴兴欣新材料股份有限 公司首次公开发行股票并在主板上市项目持续督导保荐代表人的通知》。国盛证 券作为公司首次公开发行股票的保荐机构，指定韩逸驰先生和孙蓓女士作为保荐 代表人，负责公司的持续督导工作，持续督导期至2025年12月31日止。鉴于孙蓓 女士本人工作变动原因，不再继续承担持续督导的保荐工作。为保证持续督导工 作的有序进行，国盛证券现委派保荐代表人储伟先生（简历见附件）接替孙蓓女 士担任公司的持续督导保荐代表人，继续履行持续督导项目职责。 本次变更后，公司持续督导的保荐代表人为韩逸驰先生和储伟先生。本次变 更不影响国盛证券对公司的持续督导工作，公司董事会对孙蓓女士在担任公司保 荐代表人期间所做的工作表示衷心感谢！ 特此公告。 绍兴兴欣新材料股份有限公司 证券代码：001358 证券简称：兴欣新材 公告编号：2024-026 绍兴兴欣新材料股份有限公司 关于更换保荐代表人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 董事会 202 ...

绍兴兴欣新材料股份有限公司 2024 年第一季度报告 证券代码：001358 证券简称：兴欣新材 公告编号：2024-025 绍兴兴欣新材料股份有限公司 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第一季度报告是否经审计 □是 否 1 绍兴兴欣新材料股份有限公司 2024 年第一季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 2024 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 □是 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 107,192,243.34 | 198,158,313.35 | -45.91% | | 归属于上市 ...

证券代码：001358 证券简称：兴欣新材 公告编号：2024-024 绍兴兴欣新材料股份有限公司 2023年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 绍兴兴欣新材料股份有限公司（以下简称"公司"）2023年年度权益分派方 案已获2024年4月15日召开的2023年年度股东大会审议通过，现将权益分派事宜 公告如下： 一、股东大会审议通过权益分派方案的情况 1、公司于2024 年4月16 日召开了 2023年年度股东大会，审议通过了《关 于公司2023年度利润分配方案的议案》，具体内容如下：公司拟以未来实施权益 分派时股权登记日的总股本为基数，向全体股东每10股派发现金股利12元人民币 （含税），以资本公积金中的股本溢价向全体股东每10股转增4股，不送红股， 剩余未分配利润结转以后年度分配。以截止2023年12月31日的总股本8,800万股 为基数测算，预计派发现金股利人民币10,560万元，以股本溢价转增3,520万股， 转增后公司总股本为12,320万股。在实施权益分派的股权登记日前公司总股本发 生变动的，公司拟按照现金分红比例不 ...

证券代码：001358 证券简称：兴欣新材 公告编号：2024-023 绍兴兴欣新材料股份有限公司 2023年年度股东大会决议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决提案的情况； 2、本次股东大会未涉及变更以往股东大会已通过的决议的情况。 一、会议召开情况 1.会议召开的日期、时间： （1）现场会议时间：2024年4月15日（星期一）14：00； （2）网络投票时间： 通过深圳证券交易所交易系统进行网络投票的具体时 间为2024年4月15日（星期一）上午9:15－9:25、9:30-11:30和下午13:00－15:00； 通过深圳证券交易所互联网投票系统投票的具体时间为2024年4月15日（星 期一）上午9:15至下午15:00期间的任意时间。 2.会议召开地点：浙江省绍兴市上虞区杭州湾经济技术开发区拓展路2号绍 兴兴欣新材料股份有限公司研发楼二楼大会议室。 3.会议召开方式：现场表决与网络投票相结合的方式。 4．会议召集人：公司第二届董事会 5．会议主持人：董事长叶汀先生 6.会议的召集、召开符合《中华 ...

股东大会律师见证法律意见书 北京炜衡（宁波）律师事务所 关于 绍兴兴欣新材料股份有限公司 2023 年年度股东大会的 法律意见书 地址：浙江省宁波市高新区新材料创新中心西区 B1 幢 12A 楼 电话：0574—89216932 传真：0574—87066991 网址：http://www.nbwhlaw.com/ | 目 录 1 | | --- | | 一、本次股东大会的召集和召开程序 3 | | （一）本次股东大会的召集程序 3 | | （二）本次股东大会的召开程序 3 | | 二、出席本次股东大会会议人员和召集人的资格 4 | | （一）出席本次股东大会的股东及委托代理人 4 | | （三）本次股东大会召集人资格 4 | | 三、本次股东大会的表决程序和表决结果 5 | | （一）本次股东大会的表决程序 5 | | （二）本次股东大会的表决结果 5 | | 四、结论意见 8 | 股东大会律师见证法律意见书 北京炜衡（宁波）律师事务所 关于绍兴兴欣新材料股份有限公司 2023 年年度股东大会的 法律意见书 致：绍兴兴欣新材料股份有限公司 北京炜衡（宁波）律师事务所（以下简称"本所"）依法接受绍兴兴欣新材 ...

证券代码：001358 证券简称：兴欣新材 公告编号：2024-022 一、对外投资概述 绍兴兴欣新材料股份有限公司（以下简称"公司"）为进一步拓宽业务， 延伸产业链布局，持续提升核心竞争力，实现整体发展战略，以自有资金 500 万人民币在杭州投资设立全资子公司虞欣（杭州）新材料有限公司（以下简称 "子公司"）。目前，该子公司已经完成工商注册登记并取得杭州市萧山区市 场监督管理局颁发的营业执照。 根据《深圳证券交易所股票上市规则》《公司章程》等相关规定，本次对 外投资在董事会授权总经理审批权限范围内，无需提交董事会、股东大会审议， 亦不属于关联交易和重大资产重组事项。 二、设立子公司的基本情况 注册名称：虞欣（杭州）新材料有限公司 企业类型：有限责任公司（自然人投资或控股的法人独资） 公司地址：浙江省杭州市萧山区盈丰街道朝龙大厦 1 幢 2001 室 注册资本：伍佰万元人民币 法定代表人：严利忠 出资方式：现金出资（自有或自筹资金） 股东出资额及比例：公司出资额占注册资本总额的 100%； 成立日期：2024 年 4 月 2 日 统一社会信用代码：91330109MADEJ2BTX0 经营范围：一般项目：化工 ...

一、股票交易异常波动的情况介绍 绍兴兴欣新材料股份有限公司（以下简称"公司"）股票（证券简称：兴欣 新材，证券代码：001358）于 2024 年 3 月 26 日、3 月 27 日连续两个交易日收 盘价格涨幅偏离值累计超过了 20%，根据深圳证券交易所的有关规定，属于股票 交易异常波动的情况。 二、公司关注、核实情况说明 针对公司股票异常波动，公司董事会进行了全面自查，并通过电话及书面 问询等方式，对公司控股股东、实际控制人就相关问题进行了核实，核实情况 如下： 1、公司前期披露的信息不存在需要更正、补充之处； 2、公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生 较大影响的未公开重大信息； 证券代码：001358 证券简称：兴欣新材 公告编号：2024-021 绍兴兴欣新材料股份有限公司 股票交易异常波动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 经公司董事会确认，公司目前没有任何根据《深圳证券交易所股票上市规 则》 等有关规定应予以披露而未披露的事项或与该事项有关的筹划、商谈、意向、 协 议等；董事会也未获悉本公司根据《深圳证券 ...

Financial Performance - The company's operating revenue for 2023 was ¥630,244,378.84, a decrease of 18.62% compared to ¥774,471,928.18 in 2022[22]. - The net profit attributable to shareholders for 2023 was ¥141,576,780.80, down 32.23% from ¥208,895,138.69 in 2022[22]. - The net cash flow from operating activities increased by 6.05% to ¥112,329,628.19 in 2023, compared to ¥105,918,826.18 in 2022[22]. - The total assets at the end of 2023 reached ¥1,673,599,805.32, reflecting a 126.06% increase from ¥740,339,044.02 at the end of 2022[22]. - The basic earnings per share for 2023 was ¥2.15, a decline of 32.18% from ¥3.17 in 2022[22]. - The company reported a weighted average return on equity of 22.28% for 2023, down from 45.35% in 2022, a decrease of 23.07%[22]. - The net profit after deducting non-recurring gains and losses for 2023 was ¥138,924,142.66, a decrease of 32.89% from ¥206,997,094.67 in 2022[22]. - The company experienced a quarterly decline in net profit, with the fourth quarter showing only ¥12,881,256.88 compared to ¥50,274,830.86 in the first quarter[27]. - The company achieved operating revenue of CNY 630.24 million, a decrease of 18.62% compared to the previous year[61]. - Net profit attributable to shareholders was CNY 141.58 million, down 32.23% year-on-year[61]. Governance and Compliance - The financial report confirms that all board members attended the meeting to review the annual report, ensuring accountability for the report's accuracy[4]. - The company has established a clear framework for governance and compliance, ensuring adherence to regulatory requirements[4]. - The company adheres to legal requirements for corporate governance, ensuring fair treatment of all shareholders, particularly minority shareholders[115]. - The company has established a board of directors consisting of 7 members, including 3 independent directors, complying with legal and regulatory requirements[116]. - The company has a performance evaluation and incentive mechanism in place for directors, supervisors, and senior management, ensuring transparency and compliance with legal regulations[117]. - The company emphasizes information disclosure, ensuring that all investors have fair access to accurate and timely information through designated media[119]. - The company maintains independence in assets, personnel, finance, organization, and business, ensuring no competition or unfair transactions with controlling shareholders[120][121][123]. - The company has established a dedicated investor relations management system to foster good communication and interaction with investors[119]. - The company has a complete financial accounting system and independent financial decision-making capabilities, ensuring financial independence from controlling shareholders[121]. - The company has set up specialized committees under the board, including an audit committee to enhance operational efficiency and oversight[116]. Risk Management - The company emphasizes the importance of risk awareness regarding future plans and performance forecasts, highlighting potential risks in the "Management Discussion and Analysis" section[4]. - The company faces risks from raw material price fluctuations, which could impact net profit and gross margin, but has established stable supply channels to mitigate these risks[108]. - Environmental protection risks are acknowledged, with measures in place to update equipment and ensure compliance with pollution standards[110]. - Safety production risks are managed through strict storage and transportation protocols for hazardous chemicals[111]. - The company has established a comprehensive risk assessment mechanism to identify and manage various risks, including policy, technology, market, and financial risks[163]. - The company has implemented a major risk early warning mechanism and emergency response procedures to handle potential significant risks effectively[163]. Environmental Responsibility - The company has established a comprehensive utilization of water and heat energy, aligning with green and sustainable development principles[54]. - The company’s production processes are designed to minimize waste generation and energy consumption, contributing to environmental sustainability[52]. - The company has implemented all necessary measures to comply with environmental laws and regulations[181]. - The company reported a total VOCs emission of 13.05 tons, adhering to the prescribed emission standards[182]. - The company has established online monitoring devices for wastewater and air emissions, with no exceedances reported during the reporting period[188]. - The company has invested in improving environmental protection facilities and increasing relevant environmental investments[186]. - The company has not experienced any major environmental pollution incidents or violations during the reporting period[186]. - The company is focused on reducing emissions and improving environmental compliance through new technologies and processes[184]. - The company has developed an emergency response plan for environmental incidents, enhancing safety and environmental management[189]. Research and Development - The company is focused on expanding its market presence and developing new products and technologies, although detailed metrics are not specified in the available documents[3]. - R&D expenses totaled CNY 25.51 million, with multiple projects completed during the year, emphasizing innovation as a key growth driver[62]. - The company has a strong R&D team that has achieved significant technological advancements in the piperazine derivative production field[50]. - The number of R&D personnel increased to 51 in 2023, representing a growth of 24.39% compared to 41 in 2022[77]. - R&D investment amounted to ¥25,507,244.58 in 2023, a decrease of 12.40% from ¥29,119,052.26 in 2022, while the R&D investment as a percentage of operating revenue rose to 4.05% from 3.76%[77]. - The company is focusing on new product development, including catalysts and synthetic materials, which are expected to enhance sales revenue in the future[76]. - The company has developed a complete piperazine derivatives industrial chain, including products like N-hydroxyethyl piperazine and triethylene diamine, maintaining industry-leading levels in variety, capacity, and performance[42]. Employee Development - The company has established a comprehensive internal training system to enhance employee skills and overall quality[152]. - The company emphasizes employee development and satisfaction through a well-defined human resources policy[161]. - The total number of employees at the end of the reporting period is 333, including 220 at the parent company and 113 at major subsidiaries[150]. - The company has 207 production personnel, 10 sales personnel, 51 technical personnel, 9 financial personnel, 29 administrative personnel, and 27 other personnel[150]. - The educational background of employees includes 10 with postgraduate degrees, 83 with bachelor's degrees, 81 with associate degrees, and 159 with vocational or lower education levels[150]. Shareholder Engagement - The company plans to distribute a cash dividend of 12 RMB per 10 shares (including tax) and to increase capital by 4 shares for every 10 shares held[4]. - The total distributable profit available to shareholders is RMB 495,262,926.56[155]. - The company reported a cash dividend of RMB 10,560,000, which is 100% of the total profit distribution amount[155]. - The company has not proposed any cash dividend distribution plan despite having positive distributable profits for the reporting period[154]. - The company has not conducted any cash dividends in the current reporting period, focusing instead on funding for R&D projects[154]. Market Position and Strategy - The company has become a leading manufacturer of piperazine derivatives, holding a significant market share in the global piperazine derivatives segment[42]. - The company is focused on expanding its market share through the gradual production of its fundraising projects[42]. - The company’s piperazine series products are widely used in electronic chemicals, environmental chemicals, and pharmaceuticals, with demand expected to continue growing[38]. - The company aims to enhance customer loyalty and expand market share by aligning product development with market demand in 2024[104]. - The company anticipates increased market competition, particularly from large foreign chemical enterprises, and plans to focus on organic amine fine chemicals to maintain its competitive edge[109]. Awards and Recognition - The company has received multiple awards for its technological achievements, including the first prize for scientific and technological progress from the Ministry of Education[50]. - The company has been recognized with multiple awards, including the first prize of the Ministry of Education for scientific and technological progress[128].